We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.1B
AUM Growth
+$346M
Cap. Flow
+$98.2M
Cap. Flow %
2.39%
Top 10 Hldgs %
28.43%
Holding
1,220
New
75
Increased
171
Reduced
308
Closed
104

Top Buys

Rank Stock Value
1
AON icon
Aon
AON
+$24.5M
2
WU icon
Western Union
WU
+$13.5M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.3M
4
LH icon
Labcorp
LH
+$11.5M
5
AVGO icon
Broadcom
AVGO
+$8.02M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.5M
2
GNRC icon
Generac Holdings
GNRC
+$9.38M
3
AAPL icon
Apple
AAPL
+$6.23M
4
MSFT icon
Microsoft
MSFT
+$3.53M
5
HAS icon
Hasbro
HAS
+$3.46M

Sector Composition

Rank Sector Weight
1 Technology 25.55%
2 Healthcare 16.77%
3 Financials 13.8%
4 Consumer Discretionary 11.07%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
1151
Repligen
RGEN
$7.44B
-210
Closed -$41K
RLAY icon
1152
Relay Therapeutics
RLAY
$4.02B
-979
Closed -$34K
RNR icon
1153
RenaissanceRe
RNR
$13.8B
-116
Closed -$19K
RPTX
1154
DELISTED
Repare Therapeutics
RPTX
-2
Closed
RUN icon
1155
Sunrun
RUN
$2.37B
-26
Closed -$2K
RYTM icon
1156
Rhythm Pharmaceuticals
RYTM
$7B
-1,701
Closed -$36K
SANA icon
1157
Sana Biotechnology
SANA
$885M
-391
Closed -$13K
SCHC icon
1158
Schwab International Small-Cap Equity ETF
SCHC
$5.36B
$0 ﹤0.01%
7
-160
-96% -$6.68K
SCHE icon
1159
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$0 ﹤0.01%
14
-349
-96% -$11.3K
SCHF icon
1160
Schwab International Equity ETF
SCHF
$65.6B
$0 ﹤0.01%
22
-496
-96% -$9.8K
SCHH icon
1161
Schwab US REIT ETF
SCHH
$11.7B
$0 ﹤0.01%
8
-190
-96% -$4.22K
SCHR
1162
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
-58
Closed -$2K
SENS icon
1163
Senseonics Holdings Inc
SENS
$254M
-151
Closed -$8K
SHAK icon
1164
Shake Shack
SHAK
$2.3B
-1,243
Closed -$140K
SMG icon
1165
ScottsMiracle-Gro
SMG
$4.03B
-196
Closed -$48K
SNAP icon
1166
Snap
SNAP
$7.32B
-1,055
Closed -$55K
SNOW icon
1167
Snowflake
SNOW
$92.9B
-27
Closed -$6K
SPIB icon
1168
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$0 ﹤0.01%
1
-41
-98% -$1.5K
SRVR icon
1169
Pacer Data & Infrastructure Real Estate ETF
SRVR
$379M
-150
Closed -$5K
SSTI icon
1170
SoundThinking
SSTI
$107M
-951
Closed -$33K
STOK icon
1171
Stoke Therapeutics
STOK
$1.82B
-218
Closed -$8K
SWK icon
1172
Stanley Black & Decker
SWK
$14.2B
$0 ﹤0.01%
1
-81
-99% -$16.8K
TAL icon
1173
TAL Education Group
TAL
$5.71B
-325
Closed -$18K
TEVA icon
1174
Teva Pharmaceuticals
TEVA
$35.9B
-50
Closed -$1K
TLRY icon
1175
Tilray
TLRY
$479M
0

Similar funds

HM Payson & Co's Q2 2021 Portfolio in Review

As of Q2 2021, HM Payson & Co held 1,220 positions worth $4.1B, up 9.2% from $3.76B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

HM Payson & Co's Q2 2021 filing shows 75 new, 171 increased, 308 reduced and 104 closed positions. Its largest new stake was Vanguard Ultra-Short Bond ETF: 62,900 shares worth $3.15M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $14.5M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2021 buy was Vanguard Ultra-Short Bond ETF: 62,900 shares worth $3.15M.
  • HM Payson & Co added most to Aon in Q2 2021, an estimated $24.5M increase.
  • HM Payson & Co's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.5M.
  • HM Payson & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.66M.
  • HM Payson & Co's ten largest holdings make up 28% of its $4.1B portfolio in Q2 2021.
  • HM Payson & Co opened 75 new positions and closed 104 in Q2 2021.
  • HM Payson & Co's portfolio value rose 9.2% quarter-over-quarter to $4.1B.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.